Last Updated: 2/27/2007

Clinical Interests
Laparoscopic surgery for urologic malignancies
Robotic surgery

Research Interests
Improving outcomes from surgery for genitourinary malignancies
Renal cell carcinoma
Prostatic cancer

Recent Accomplishments and Honors
2005-2006 "Best Doctors in America"
2004-2005 Faculty Teaching Award ("Attending of the Year"), Division of Urology
2005-2006 Faculty Teaching Award ("Attending of the Year"), Division of Urology
2004 North Carolina Urology Seminar, First Prize, Research
2004 North Carolina Urology Seminar, Third Prize, Case Research
2003 North Carolina Urology Seminar, Second Prize, Research
2002- Harmes Scholar Research Fellowship, Dartmouth-Hitchcock Department of Surgery

Training
UCLA School of Medicine, Los Angeles, CA, M.D., 1994, Medicine
Stanford University, Stanford, California, 1994-95, Internship, General Surgery
Stanford University, Stanford, California, 1995-96, Residency, General Surgery
Stanford University, Stanford, California, 1996-2000, Residency, Urology

Publications
Fielding JR, Borland D, Lee KH, Clarke J, Wallen E, Pruthi R, and Taylor RM. Virtual pyeloscopy using volumetric depth peeling. Acad Radiol 2006; 13:759-763

Pruthi RS, Tornehl C, Gaston K, Lee K, Moore D, Carson CC, Wallen EM. Impact of race, age income, and residence on prostate cancer knowledge, screening behavior, and health maintenance in siblings of patients with prostate cancer. Eur Urol, 2006; 64-69

Pruthi RS, Derksen JE, Moore D, Carson CC, Grigson G, Watkins C, Wallen E. Phase II trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive radiation therapy or radical prostatectomy. Clin Cancer Res 2006; 12(7):2172-7.

Pruthi RS, Hubbard JS, Kouba E, Funkhouser W, Wallen E. Large presacral
schwannoma after radical prostatectomy. Eur Urol 2006; 49(5):914-7. Epub 2006 Feb 24.

Pruthi RS, Wallen EM. Cyclooxygenase-2: a therapeutic target for prostate cancer.
Clinc Genitourin Cancer, 2005; 4(3):2003-11.

Carson CC, Hubbard JS, Wallen E. Erectile dysfunction and treatment of carcinoma of the prostate. Curr Urol Rep, 2005; 6(6):461-9.

Stefaniak HM, Wallen E, Pruthi RS The Contribution of race to prostate cancer outcome-tumor biology versus socioeconomic and behavioral factors. Contemporary Urology, April 2005;66-70.

Kouba E, Tornehl C, Wallen E, Pruthi RS. Partial nephrectomy with fibrin glue repair: measurement of vascular and pelvicaliceal bond integrity in a live porcine and isolated abbatoir animal model. Journal of Urology, 172:326-30,2004.

Schwaab T., Tretter C.P., Gibson J.l, Cole B.F., Schned AR., Harris R., Wallen E.M., Fisher J.L, Waugh M.G., Truman D., Stempkowski LM., Crosby N.A., Heaney lA, Ernstoff, M.S.: Immunological effects of granulocyte-macrophage colony-stimulating factor and autologous tumor vaccine in patients with renal cell carcinoma. J. Urol. 2004 Mar;171(3):1036-42.
Vidanes, G.M., Paton, V., Wallen, E., Peehl, D.M., Navone, N., Brooks, lD.:Silencing ofpi-c1ass glutathione S-transferase ill MDA PCa 2a and MDA PCa 2b cells. Prostate. 2002 Jun 1; 51(4):225-30.
Wallen, E.M., Sellers, R.G., Peehl, D.A: Brefeldin A induces p53-independent apoptosis in primary cultures of human prostatic cancer cells. J Urol. 2000 Sep; 164 (3 Pt 1): 836-41.
Terris, M.K., Wallen, E.M., Stamey, T.A: Comparison of mid-lobar versus lateral systematic sextant biopsies in the detection of prostate cancer. Urologia Intemationalis 59(4),239-242, 1997.

E-mail: ewallen@med.unc.edu
Telephone: 9199669696
FAX: 9199660098
Address: , NC

Click here to update this profile